Hvis patienten udvikler hypoglykæmi, er det nødvendigt at vende tilbage til særskilte tabletter, så doseringen af glimepirid kan justeres.
The dose can be increased to the 8 mg/ 4 mg tablets after eight weeks if needed, but this should be done with caution, due to the risk of fluid retention.